These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 371060)

  • 1. [Bioavailability and "first pass" effect of a drug].
    Jacquot C
    Therapie; 1978; 33(6):683-97. PubMed ID: 371060
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral bioavailability and first-pass effects.
    Kwan KC
    Drug Metab Dispos; 1997 Dec; 25(12):1329-36. PubMed ID: 9394021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.
    Pang KS; Chow EC
    Drug Metab Dispos; 2012 Oct; 40(10):1869-77. PubMed ID: 22745334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
    Raaflaub J
    Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
    Cho HJ; Kim JE; Kim DD; Yoon IS
    Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of pharmacokinetics between humans and monkeys.
    Akabane T; Tabata K; Kadono K; Sakuda S; Terashita S; Teramura T
    Drug Metab Dispos; 2010 Feb; 38(2):308-16. PubMed ID: 19910513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of first to zeroth moments of the plasma profile of an oral drug undergoing first-pass and linear reversible metabolism.
    Cheng H
    Biopharm Drug Dispos; 1995 Dec; 16(9):791-6. PubMed ID: 8580402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics in clinical practice. I. Concepts.
    Gibaldi M; Levy G
    JAMA; 1976 Apr; 235(17):1864-7. PubMed ID: 946488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Route of administration and drug disposition.
    Gibaldi M; Perrier D
    Drug Metab Rev; 1974; 3(2):185-99. PubMed ID: 4607867
    [No Abstract]   [Full Text] [Related]  

  • 11. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient method for estimating the quantity of drug eliminated by the routes other than hepatic metabolism and renal excretion and the fraction of drug that reaches the "first pass" after oral administration.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):828-33. PubMed ID: 16489605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the potential role of intestinal first-pass metabolism for the prediction of drug-drug interactions: the role of PBPK modeling.
    Alqahtani S; Bukhari I; Albassam A; Alenazi M
    Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):625-634. PubMed ID: 29806951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments of in silico predictions of oral bioavailability.
    Zhu J; Wang J; Yu H; Li Y; Hou T
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):362-74. PubMed ID: 21470180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring.
    Dvorchik BH; Vesell ES
    Clin Chem; 1976 Jun; 22(6):868-78. PubMed ID: 776451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loosening the ties that bind--novel strategy to enhance oral bioavailability.
    Barrett KE
    Mol Pharmacol; 2003 Dec; 64(6):1279-82. PubMed ID: 14645657
    [No Abstract]   [Full Text] [Related]  

  • 17. First-pass metabolism.
    Brodie MJ
    Practitioner; 1983 Oct; 227(1384):1619-27. PubMed ID: 6634632
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data.
    Somogyi A; Eichelbaum M; Gugler R
    Eur J Clin Pharmacol; 1982; 22(1):85-90. PubMed ID: 7094978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.
    Pang KS; Gillette JR
    J Pharm Sci; 1978 May; 67(5):703-4. PubMed ID: 641815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.